drugset / Trial / NCT03921775

A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery

NCT03921775

Phase 3 Completed 330 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

The study is being conducted to evaluate the efficacy and safety of remimazolam tosilate compared to propofol for general anesthesia during elective surgery.

Timeline

Start
2019-05-13
Primary completion
2019-12-30
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 3 mg/kg Intravenous
Comparator Propofol Small molecule 12 mg/kg Intravenous
Subject Remimazolam Small molecule 1 mg/kg Intravenous

Indications

No indication recorded.